Skip to content

Clinical trials

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Country / region: France Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20081
20092
20101
20111
20121
20151
20173
20191
20212
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Recruiting3
Unknown status3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Princess Maxima Center for Pediatric Oncology3
Allotera Therapeutics1
Boston Medical Center1
Bristol-Myers Squibb1
Cellestia Biotech AG1
Centre Hospitalier Universitaire Dijon1
Children's Oncology Group1
Daiichi Sankyo1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma23
Precursor Cell Lymphoblastic Leukemia-Lymphoma14
Leukemia9
Burkitt Lymphoma8
Lymphoma, Non-Hodgkin8
Recurrence8
Hodgkin Disease7
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Follicular7

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.